FDA approves Olysio to treat chronic hepatitis C
The U.S. Food and Drug Administration yesterday approved Olysio (simeprevir), a new therapy to treat chronic hepatitis C virus infection. Image/Video Screen Shot Hepatitis C is a viral disease that causes inflammation More...
Hepatitis C drug, Incivek, linked to fatal skin reactions
IncivekImage/Vertex Pharmaceuticals-Business Wire Cambridge, MA company, Vertex Pharmaceuticals Inc, announced Wednesday that hepatitis C drug, Incivek (generic: telaprevir) has received a black boxed warning More...
